We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+11.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$42.5B
AUM Growth
+$3.46B
(+8.8%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
48.81%
Holding
311
New
17
Increased
72
Reduced
106
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$542M |
| 2 |
Microsoft
MSFT
|
+$231M |
| 3 |
Blackstone
BX
|
+$104M |
| 4 |
Caterpillar
CAT
|
+$98M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$90.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$150M |
| 2 |
Intuit
INTU
|
+$141M |
| 3 |
ASML
ASML
|
+$124M |
| 4 |
Intuitive Surgical
ISRG
|
+$120M |
| 5 |
Verisk Analytics
VRSK
|
+$96.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Financials | 17.95% |
| 3 | Consumer Staples | 10.49% |
| 4 | Communication Services | 9.83% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Alcon
ALC
$34.8B
| – | – |
-5,149
| Closed | -$388K |
|
302
Boston Scientific
BSX
$68B
| – | – |
-5,369
| Closed | -$337K |
|
303
Carlyle Group
CG
$17B
| – | – |
-5,399
| Closed | -$261K |
|
304
Check Point Software Technologies
CHKP
$14B
| – | – |
-45,011
| Closed | -$6.43M |
|
305
HDFC Bank
HDB
$120B
| – | – |
-360,374
| Closed | -$8.97M |
|
306
Occidental Petroleum
OXY
$60.6B
| – | – |
-5,451
| Closed | -$354K |
|
307
Pool Corp
POOL
$6.69B
| – | – |
-1,034
| Closed | -$209K |
|
308
Tractor Supply
TSCO
$18B
| – | – |
-7,630
| Closed | -$346K |
|
309
Xylem
XYL
$25.2B
| – | – |
-2,764
| Closed | -$330K |
|
310
Yum China
YUMC
$14.9B
| – | – |
-4,945
| Closed | -$241K |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q2 2026 Portfolio in Review
As of Q2 2026, Fayez Sarofim & Co held 311 positions worth $42.5B, up 8.8% from $39.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Fayez Sarofim & Co's Q2 2026 filing shows 17 new, 72 increased, 106 reduced and 11 closed positions. Its largest new stake was AstraZeneca: 179,593 shares worth $34.1M. The largest sale was Texas Instruments, an estimated $150M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q2 2026 buy was AstraZeneca: 179,593 shares worth $34.1M.
- Fayez Sarofim & Co added most to Broadcom in Q2 2026, an estimated $542M increase.
- Fayez Sarofim & Co's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $150M.
- Fayez Sarofim & Co fully exited HDFC Bank in Q2 2026, selling an estimated $8.97M.
- Fayez Sarofim & Co's ten largest holdings make up 49% of its $42.5B portfolio in Q2 2026.
- Fayez Sarofim & Co opened 17 new positions and closed 11 in Q2 2026.
- Fayez Sarofim & Co's portfolio value rose 8.8% quarter-over-quarter to $42.5B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.